SIGA Technologies, Inc. (NASDAQ:SIGA) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its holdings in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 39.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 244,857 shares of the company’s stock after buying an additional 69,006 shares during the period. Victory Capital Management Inc. owned about 0.34% of SIGA Technologies worth $1,858,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of SIGA. Steward Partners Investment Solutions LLC acquired a new stake in shares of SIGA Technologies in the fourth quarter valued at about $58,000. Bayesian Capital Management LP purchased a new position in SIGA Technologies in the first quarter valued at about $97,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after acquiring an additional 3,829 shares during the period. Lazard Asset Management LLC purchased a new stake in shares of SIGA Technologies during the 1st quarter worth approximately $105,000. Finally, EntryPoint Capital LLC acquired a new stake in shares of SIGA Technologies in the 1st quarter worth approximately $111,000. 55.40% of the stock is owned by institutional investors and hedge funds.

SIGA Technologies Price Performance

NASDAQ SIGA opened at $7.97 on Thursday. The business has a 50 day moving average price of $9.03 and a 200 day moving average price of $8.27. The company has a market capitalization of $568.82 million, a P/E ratio of 7.25 and a beta of 0.91. SIGA Technologies, Inc. has a 1-year low of $4.26 and a 1-year high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last posted its earnings results on Thursday, August 1st. The company reported $0.03 earnings per share for the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. The firm had revenue of $21.81 million during the quarter. During the same quarter last year, the business posted ($0.04) earnings per share. On average, research analysts expect that SIGA Technologies, Inc. will post 1.01 earnings per share for the current fiscal year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.